830 related articles for article (PubMed ID: 29217664)
21. Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies.
Swaisland H; Plummer R; So K; Garnett S; Bannister W; Fabre MA; Dota C; Fielding A
Cancer Chemother Pharmacol; 2016 Oct; 78(4):775-84. PubMed ID: 27553432
[TBL] [Abstract][Full Text] [Related]
22. QTc prolongation by antiepileptic drugs and the risk of torsade de pointes in patients with epilepsy.
Feldman AE; Gidal BE
Epilepsy Behav; 2013 Mar; 26(3):421-6. PubMed ID: 23218812
[TBL] [Abstract][Full Text] [Related]
23. Psychotropics and sudden cardiac death.
Gören JL; Dinh TA
R I Med J (2013); 2013 Mar; 96(3):38-41. PubMed ID: 23641438
[TBL] [Abstract][Full Text] [Related]
24. Corrected QT Interval Prolongation in Pediatric and Young Adult Patients on Methadone for Cancer-Related Pain.
Madden K; Jo E; Williams JL; Liu D; Bruera E
J Pain Symptom Manage; 2019 Oct; 58(4):678-684. PubMed ID: 31195079
[TBL] [Abstract][Full Text] [Related]
25. Life-threatening cardiac arrhythmias due to drug-induced QT prolongation : A retrospective study over 6 years from a medical intensive care unit.
Michels G; Kochanek M; Pfister R
Med Klin Intensivmed Notfmed; 2016 May; 111(4):302-9. PubMed ID: 26340799
[TBL] [Abstract][Full Text] [Related]
26. Assessing QT interval prolongation and its associated risks with antipsychotics.
Nielsen J; Graff C; Kanters JK; Toft E; Taylor D; Meyer JM
CNS Drugs; 2011 Jun; 25(6):473-90. PubMed ID: 21649448
[TBL] [Abstract][Full Text] [Related]
27. Domperidone-Associated QT Interval Prolongation in Non-oncologic Pediatric Patients: A Review of the Literature.
Morris AD; Chen J; Lau E; Poh J
Can J Hosp Pharm; 2016; 69(3):224-30. PubMed ID: 27403002
[TBL] [Abstract][Full Text] [Related]
28. [Drug-induced QT interval prolongation: do we know the risks?].
Villamañán E; Armada E; Ruano M
Med Clin (Barc); 2015 Mar; 144(6):269-74. PubMed ID: 24656122
[TBL] [Abstract][Full Text] [Related]
29. QT interval measurement in ventricular pacing: Implications for assessment of drug effects and pro-arrhythmia risk.
Schurr JW; Grewal PK; Fan R; Rashba E
J Electrocardiol; 2022; 70():13-18. PubMed ID: 34826635
[TBL] [Abstract][Full Text] [Related]
30. Relation of B-type natriuretic peptide level in heart failure to sudden cardiac death in patients with and without QT interval prolongation.
Vrtovec B; Knezevic I; Poglajen G; Sebestjen M; Okrajsek R; Haddad F
Am J Cardiol; 2013 Mar; 111(6):886-90. PubMed ID: 23273526
[TBL] [Abstract][Full Text] [Related]
31. Methadone Therapy in Underserved Urban Community: QTc Prolongation and Life-Threatening Ventricular Arrhythmias.
Chowdhury M; Wong J; Cheng A; Khilkin M; Palma E
Cardiovasc Ther; 2015 Jun; 33(3):127-33. PubMed ID: 25825202
[TBL] [Abstract][Full Text] [Related]
32. Risk of QTc Interval Prolongation Associated With Circulating Anti-Ro/SSA Antibodies Among US Veterans: An Observational Cohort Study.
Lazzerini PE; Cevenini G; Qu YS; Fabris F; El-Sherif N; Acampa M; Cartocci A; Laghi-Pasini F; Capecchi PL; Boutjdir M; Lazaro D
J Am Heart Assoc; 2021 Feb; 10(4):e018735. PubMed ID: 33533258
[TBL] [Abstract][Full Text] [Related]
33. Congenital long QT syndrome: severe torsades de pointes provoked by epinephrine in a digenic mutation carrier.
Tan VH; Duff H; Kuriachan V; Gerull B
Heart Lung; 2014; 43(6):541-5. PubMed ID: 25236808
[TBL] [Abstract][Full Text] [Related]
34. Dostarlimab, an anti-programmed death-1 monoclonal antibody, does not cause QT prolongation in patients with solid tumours: A concentration-QT analysis.
Kuchimanchi M; Dabrowski C; Lu S; Melhem M
Br J Clin Pharmacol; 2023 Jul; 89(7):2272-2282. PubMed ID: 36823349
[TBL] [Abstract][Full Text] [Related]
35. Azithromycin-induced proarrhythmia and cardiovascular death.
Howard PA
Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766
[TBL] [Abstract][Full Text] [Related]
36. Risk of QT/QTc prolongation among newer non-SSRI antidepressants.
Jasiak NM; Bostwick JR
Ann Pharmacother; 2014 Dec; 48(12):1620-8. PubMed ID: 25204465
[TBL] [Abstract][Full Text] [Related]
37. Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity.
Staikou C; Stamelos M; Stavroulakis E
Br J Anaesth; 2014 Feb; 112(2):217-30. PubMed ID: 24305646
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study.
Ali Z; Ismail M; Nazar Z; Khan F; Khan Q; Noor S
BMC Psychiatry; 2020 Jun; 20(1):277. PubMed ID: 32493330
[TBL] [Abstract][Full Text] [Related]
39. Effects of opioid receptor agonist and antagonist medications on electrocardiogram changes and presentation of cardiac arrhythmia: review article.
Etaee F; Tobin M; Vuppala S; Komaki A; Delisle BP; Di Biase L; Catanzaro JN; Natale A; Elayi CS
J Interv Card Electrophysiol; 2022 Mar; 63(2):471-500. PubMed ID: 34674120
[TBL] [Abstract][Full Text] [Related]
40. [Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database].
Rochoy M; Auffret M; Béné J; Gautier S;
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):1-8. PubMed ID: 27988172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
